Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs

Seizure

Volumn 13, Issue 6, 2004, Pages 392-398

  Labar, Douglas ^a  

^a New York Presbyterian Cornell ^*  (United States)

Author keywords

Antiepileptic drugs; Epilepsy; Seizures; Vagus nerve stimulation

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; KRUSKAL WALLIS TEST; LENNOX GASTAUT SYNDROME; LOBECTOMY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANK SUM TEST; SEIZURE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; ELECTRIC STIMULATION THERAPY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; VAGUS NERVE;

EID: 3543066384     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2003.09.009     Document Type: Article

References (19)

1. DeGiorgio C. Schachter S. Handforth A. Salinsky M. Thompson J. Uthman B. et al. Prospective long-term study of VNS for treatment of refractory seizures Epilepsia 41 2000 1195-1200
2. Morris G. Mueller W. Andriola M. Ben-Menachem E. Case K. Collins S. et al. Long-term treatment with VNS in patients with refractory epilepsy Neurology 53 1999 1731-1735
3. Murphy J. Andriola M. Barron T. Burgerman R. George R. Gilmartin R. et al. Left VNS: Experience in 60 children with pharmacoresistant epilepsy J. Pediatr. 134 1999 563-566
4. Salinsky M. Uthman B. Ristanovic R. Wernicke J. Tarver W. George R. et al. VNS for the treatment of medically intractable seizures Arch. Neurol. 53 1996 1176-1180
5. Parker A. Polkey C. Binnie C. Madigan C. Ferrie C. Robinson R. VNS in epileptic encephalopathies Pediatrics 103 1999 778-782
6. Labar D. AED use during the first 12 months of VNS Neurology 59 Suppl. 4 2002 S38-S43
7. DeGiorgio C. Thompson J. Lewis P. Arrambide S. Naritoku D. Handforth A. et al. VNS: analysis of device parameters in 154 patients during long-term XE5 study Epilepsia 42 2001 1017-1020
8. Binnie C. VNS for epilepsy: a review Seizure 9 2000 161-169
9. Heck C. Helmers S. Degiorgio C. VNS stimulation therapy, epilepsy, and device parameters Neurology 59 Suppl. 4 2002 S31-S37
10. Schacter S. Saper C. Vagus nerve stimulation Epilepsia 39 1998 677-686
11. Wernicke J. Holder L. Keenan S. Lunney S. Tarver B. Response predictors for VNS in the treatment of refractory partial epilepsy Epilepsia 33 Suppl. 3 1992 S101
12. Hornig G. Murphy J. Schallert G. Tilton C. Left VNS in children with refractory epilepsy South. Med. J. 90 1997 481-488
13. Tarver B. VNS clinical studies-predictors of response. PMAA/USFDA presentation, 1997.
14. Labar D. Murphy J. Tecoma E. Sala D. Burgerman R. Gilmartin R. et al.VNS for medication-resistant generalized epilepsy Neurology 52 1999 1510-1512
15. Patwardhan R. Stong B. Bebin E. Mathisen J. Grabb P. Efficacy of VNS in children with medically refractory epilepsy Neurosurgery 47 2000 1353-1358
16. Frost M. Gates J. Helmers S. Wheless J. Levisohn P. Tardo C. et al.VNS in children with refractory seizures associated with LGS Epilepsia 42 2001 1148-1152
17. Helmers S. Wheless J. Frost M. Gates J. Levisohn P. Tardo C. et al. VNS therapy in pediatric patients with refractory epilepsy: retrospective study J. Child Neurol. 16 2001 843-848
18. Refroe J. Wheless J. Earlier use of adjunctive VNS therapy for refractory epilepsy Neurology 59 Suppl. 4 2002 S26-S31
19. Sirvin J. Sperling M. Naritoku D. Schachter S. Labar D. Holmes M. et al. Efficacy and tolerability of VNS therapy for epilepsy in older adults Neurology 54 2000 1179-1182